Hsiou-Chi Liou
ImmuneTarget, Inc
Affiliations
Weill Cornell Medicine
Technologies
Therapeutic
Indication
Allergy/Asthma
Autoimmune & Inflammation
Cardiovascular Disease
Drug Discovery
Fibrosis
Oncology
Website
jlabs.jnjinnovation.comOur mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases.